Intelligence Hub
Market analytics and operational performance indicators
144 - August 30, 2023
Director Michael Griffin files Form 144 to sell 38,090 RKLB shares worth $242K.
Brief
This Form 144 discloses Director Michael D. Griffin's intent to sell 38,090 common shares of Rocket Lab USA, Inc. on or around 08/30/2023, acquired via restricted stock vesting on 06/14/2023 as compensation, with aggregate market value of $241,614. Griffin sold 50,689 shares on 06/06/2023; the filing certifies no undisclosed material adverse information.
Detailed Brief
Form 144 is a notice of proposed sale of restricted securities under Rule 144 by affiliates like directors. Here, Rocket Lab USA, Inc. (NASDAQ: RKLB) Director Michael D. Griffin reports plans to sell 38,090 common shares through Fidelity Brokerage Services LLC. Shares were acquired on 06/14/2023 from restricted stock unit vesting as compensation from the issuer. The proposed sale date is 08/30/2023, with aggregate market value $241,614 based on outstanding shares of 483,326,614. In the past 3 months, Griffin sold 50,689 shares on 06/06/2023 for $253,445 gross proceeds via a Logiq Inc account where he is a stakeholder. The filing includes the required representation of no known undisclosed material adverse information regarding the issuer.
Key Telemetry
- • Director Michael D. Griffin to sell 38,090 common shares (market value $241,614) on ~08/30/2023.
- • Shares acquired 06/14/2023 via RSU vesting as compensation.
- • Prior sale: 50,689 shares on 06/06/2023 for $253,445.
- • Total outstanding shares: 483,326,614; certifies no undisclosed adverse info.
Impact Vector
Routine post-vesting sale by director represents minimal dilution (<0.01% of outstanding shares). No signs of distress as Griffin affirms no undisclosed adverse information. Investors should monitor for additional insider sales or patterns, but this is typical compensation liquidity event with negligible near-term impact on stock or strategy.